Search Archive
AWI has joined the Validation & Qualification Network (VQN), a public-private partnership to foster the development and use of new approach methodologies (NAMs)—innovative techniques that can help reduce and replace animals in research and testing. The partnership—launched by the Foundation for the National Institutes of Health in collaboration with the NIH—is an element of the Complement Animal
In line with its recently announced initiative to prioritize human-based research (see AWI Quarterly, summer 2025), the NIH announced in July that moving forward, all new calls for funding from the agency, known as notices of funding opportunities (NOFOs), that relate to animal experimentation must now also “support human-focused approaches such as clinical trials, real world data, or
Experiments on animals (“in vivo” experiments) have long been the norm for learning about human health and disease, because testing on live animals enables researchers to investigate how chemicals, drugs, and disease affect a whole body, including the complex interactions between organs, tissues, and other biological systems. However, there are both ethical and scientific concerns